Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-06-11

FDA Approved: DULOXETINE DELAYED-RELEASE — Original Application (Breckenridge Pharmaceutical, Inc.)

View source ↗

Summary

FDA approved Breckenridge Pharmaceutical's original generic duloxetine hydrochloride delayed-release capsules, a generic version of the antidepressant duloxetin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Duloxetine hydrochloride delayed-release capsules (Duloxetine hydrochloride)

Snippet

ORIG AP for DULOXETINE DELAYED-RELEASE (DULOXETINE HYDROCHLORIDE)